New York accuses Insys of deceptively marketing opioid

(Reuters) - New York's attorney general on Thursday filed a lawsuit against Insys Therapeutics Inc seeking $75 million from the pharmaceutical company, which he said deceptively promoted a powerful fentanyl-based cancer pain medicine for unsafe uses.

Source: Reuters: Health - February 1, 2018 Category: Consumer Health News Tags: healthNews Source Type: news